Could a dissolving scaffold replace silicone implants? new trial begins
NCT ID NCT07367698
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a breast scaffold made from polycaprolactone (PCL), an absorbable material, combined with the patient's own fat to reconstruct the breast after implant removal. It involves 73 women who want to revise their previous breast augmentation. The goal is to see if this approach is safe and effective, with follow-up for up to 5 years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
polycaprolactone (PCL) breast scaffold with autologous fat grafting
What this could lead to
If it works, this could offer a safer, more natural alternative to replacing silicone breast implants, using the body's own fat for reconstruction.
What could go wrong
This is an early-stage study with only 73 participants, so results may not apply to everyone. Risks include device-related side effects or the need for further surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST IMPLANT REVISION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Evangelisches Krankenhaus Göttingen-Weende
NOT_YET_RECRUITINGGöttingen, Lower Saxony, 37075 Göttingen, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Macquarie University Hospital
RECRUITINGSydney, New South Wales, 2109, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Royal Brisbane and Women's Hospital (RBWH), Herston Biofabrication Institute (HBI)
NOT_YET_RECRUITINGBrisbane, Queensland, 4029, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
Universitätsklinikum Münster
NOT_YET_RECRUITINGMünster, North Rhine-Westphalia, 48149 Münster, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Westmead Hospital, Lakeview Private Hospital
NOT_YET_RECRUITINGSydney, New South Wales, 2145, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
Zealand University Hospital
NOT_YET_RECRUITINGRoskilde, Region Sjælland, 4000 Roskilde, Denmark
Contact Email: •••••@•••••
Contact